References
- Tuberculosis, final data: United States, 1986. MMWR 1986: 36(50,51): 817–20
- Tuberculosis and AIDS: Connecticut. MMWR 1987: 36(9): 133–5
- Tuberculosis control among homeless populations. MMWR 1987: 36(17): 257–60
- Tuberculosis in minorities: United States. MMWR 1987: 36(6): 77–80
- Lefrock JL, Smith BR. Tuberculosis therapy. Am Fam Physician 1983: 27(3): 261–4
- Simon HB. Update on drug therapy. Consultant 1984: 24(4): 63–75
- Turico NC, Evans HC. Preventing and managing tuberculosis in children. J Respir Dis 1989: 10(6): 23–37
- Goldberger MJ. Antituberculosis agents. Med Clin North Am 1988: 72(3): 661–8
- Inselman LS. Tuberculosis in children: update on diagnosis and therapy. J Respir Dis 1983: 4(9): 11–25
- Farer LS, Snider DE Jr. Tuberculosis: current recommendations for cure and control. Postgrad Med 1988: 84(1): 58–68
- Yoskikawa TT, Fujiata NK. Antituberculosis drugs. Med Clin North Am 1982: 66(1): 209–18
- Medical Section of the American Lung Association. Treatment of tuberculosis and tuberculosis infection in adults and children. Am Rev Respir Dis 1986: 134(2): 355–63
- Castelo A, Jardim JR, Goihman S, et al. Comparison of daily and twice-weekly regimens to treat pulmonary tuberculosis. Lancet 1989: 2(8673): 1173–6
- Hong Kong TB Treatment Service/British Medical Research Council. Controlled trial of 6-month and 9-month regimens of daily and intermittent streptomycin plus isoniazid plus pyrazinamide for pulmonary tuberculosis in Hong Kong: the results up to 30 months. Am Rev Respir Dis 1977: 115(5): 727–35
- East African/British Medical Research Council. Results at 5 years of a controlled comparison of a 6-month and a standard 18-month regimen of chemotherapy for pulmonary tuberculosis. Am Rev Respir Dis 1977: 116(1): 3–8
- Dutt AK, Stead WW. Short-course treatment regimens for patients with tuberculosis. Arch Intern Med 1980: 140(6): 827–9
- Dutt AK, Stead WW. Chemotherapy of tuberculosis for the 1980s. Clin Chest Med 1980: 1(2): 243–52
- British Ṫhoracic Association. A controlled trial of six months chemotherapy in pulmonary tuberculosis. Second report: results during the 24 months after the end of chemotherapy. Am Rev Respir Dis 1982: 126(3): 460–2
- Dutt AK, Moers D, Stead WW. Short-course chemotherapy for extrapulmonary tuberculosis: nine years' experience. Ann Intern Med 1986: 104(1): 7–12
- Snider DE Jr, Rieder HL, Combs D, et al. Tuberculosis in children. Pediatr Infect Dis J 1988: 7(4): 271–8
- Mycobacterioses and the acquired immunodeficiency syndrome: Joint Position Paper of the American Thoracic Society and the Centers for Disease Control. Am Rev Respir Dis 1987: 136(2): 492–6
- Chaisson RE, Schecter GF, Theuer CP, et al. Tuberculosis in patients with the acquired immunodeficiency syndrome: clinical features, response to therapy, and survival. Am Rev Respir Dis 1987: 136(3): 570–4
- Covington TR, Di Palma JR, eds. Drug facts and comparisons. St Louis: JB Lippincott, 1990: 1674–92
- Dall L. Chemotherapy for pulmonary tuberculosis: a short-course regimen and its rationale. Postgrad Med 1983: 74(3): 73–8
- Johnson JR. Chemoprophylaxis of pulmonary tuberculosis: current recommendations and controversies. Postgrad Med 1983: 74(3): 64–9
- Snider DE Jr, Caras GJ, Koplan JP. Preventive therapy with isoniazid: cost-effectiveness of different durations of therapy. JAMA 1986: 255(12): 1579–83